Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer

被引：0
|
作者：
Kazumi Sano
Kazuhiko Nakadate
Kazuhiko Hanada
机构：
[1] Meiji Pharmaceutical University,Department of Pharmacometrics and Pharmacokinetics
[2] Meiji Pharmaceutical University,Department of Basic Biology, Educational and Research Center for Pharmacy
来源：
BMC Cancer | / 20卷
关键词：
Minocycline application; Improvement skin disorder; Afatinib; EGFR; NSCLC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Iwama, Eiji
    Nakanishi, Yoichi
    Okamoto, Isamu
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 267 - 276
  • [22] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer
    Zaarour, Mazen
    Weerasinghe, Chanudi
    Nazha, Bassel
    Hassan, Samer
    Atallah, Jean-Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1327 - 1336
  • [23] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
  • [24] Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors
    Nurwidya, Fariz
    Takahashi, Fumiyuki
    Murakami, Akiko
    Kobayashi, Isao
    Kato, Motoyasu
    Shukuya, Takehito
    Tajima, Ken
    Shimada, Naoko
    Takahashi, Kazuhisa
    RESPIRATORY INVESTIGATION, 2014, 52 (02) : 82 - 91
  • [25] Rebiopsy of Non-Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
    Hata, Akito
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Takeshita, Jumpei
    Tanaka, Kosuke
    Nanjo, Shigeki
    Fujita, Shiro
    Kaji, Reiko
    Imai, Yukihiro
    Monden, Kazuya
    Matsumoto, Takeshi
    Nagata, Kazuma
    Otsuka, Kyoko
    Tachikawa, Ryo
    Tomii, Keisuke
    Kunimasa, Kei
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    Nishimura, Yoshihiro
    CANCER, 2013, 119 (24) : 4325 - 4332
  • [26] Epidermal growth factor receptor-targeted immunomagnetic liposomes for circulating tumor cell enumeration in non-small cell lung cancer treated with epidermal growth factor receptor-tyrosine kinase inhibitors
    Cui, Shaohua
    Ni, Yiqian
    Zhao, Yizhuo
    Li, Zonghai
    Xiong, Liwen
    Liu, Jun
    Liang, Xiaofei
    Jiang, Liyan
    LUNG CANCER, 2019, 132 : 45 - 53
  • [27] Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib
    Masood, Ashiq
    Kancha, Rama Krishna
    Subramanian, Janakiraman
    SEMINARS IN ONCOLOGY, 2019, 46 (03) : 271 - 283
  • [28] Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis
    Zhang, Qiuyi
    Zhang, Xuchao
    Yan, Honghong
    Jiang, Benyuan
    Xu, Chongrui
    Yang, Jinji
    Chen, Zhihong
    Su, Jian
    Wu, Yi-Long
    Zhou, Qing
    THORACIC CANCER, 2016, 7 (06) : 648 - 654
  • [29] New era of epidermal growth factor receptor-tyrosine kinase inhibitors for lung cancer
    Joana Espiga Macedo
    World Journal of Respirology, 2016, (02) : 57 - 62
  • [30] Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    Sequist, Lecia V.
    ONCOLOGIST, 2007, 12 (03): : 325 - 330
12345